Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00002896Phase 3Unknown
Phase 3, randomised, open-label trial of fluorouracil and folinic acid in rectal cancer (2 arms), sponsored by European Institute of Oncology. Primary endpoints: Local Recurrence Rate, Cost-Benefit Ratio and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00002896.